What is the impact of concordance with rivastigmine therapy on the progression of dementia symptoms?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.19053446
Cited by: 0

Abstract

Concordance with rivastigmine therapy may contribute to modest improvements in dementia symptoms, though adherence can be challenged by adverse effects and individual variability in therapeutic response.

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Medication Adherence and Compliance Cholinesterase and Neurodegenerative Diseases

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
16 March 2026
Language
EN